That about sums it up. But, I think, with RXMD revenues are king. The company is making bank, and sooner or later, people will realize that a little debt is not a bad thing.
With a better quarter than the last one, they could almost just write a check for the remaining debt and maintain market share to realize a .10 pps.
News 
Market Data 
Discover 
